ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

ASPO Honors Gritz.

May 25, 2001

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Reed To Leave NCI Next Year; Allegra Moves To Extramural Side; Ozer Heads Okla. Center.

July 21, 2000